Notice Number: NOT-NS-18-027

Key Dates
Release Date: December 13, 2017

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants concerned with the NIH Blueprint Neurotherapeutics Network (BPN) Funding Opportunity Announcements about the areas of special interest. The National Institute of Neurological Disorders and Stroke (NINDS) is interested in receiving applications directed at identifying and developing the new small molecule pain therapies. The National Institute on Drug Abuse (NIDA) is specifically interested in receiving the highly innovative applications, entering the BPN in the discovery phase only, directed at identifying new small molecules devoid of addictive properties for the treatment of pain.

Additionally, the BPN will hold an informational webinar on the program for potential applicants. The webinar is recommended for investigators who have small molecule validated hit compounds and the disease biology assays to drive lead optimization who are interested in learning about the BPN and it virtual pharma model that brings NIH investigators together with NIH expertise, seasoned industry consultants and BPN's contract resources.

This webinar is optional and not required for submission of applications.

WEBINAR INFORMATION
Informational Webinar on the Blueprint Neurotherapeutic Network
January 3, 2018 3:30 p.m.- 4:30 Eastern Time
Please visit the following link to register for the webinar:
Link to webinar
A registration button is available at the bottom of the page.

Inquiries

Please direct all inquiries to:

Charles L. Cywin, Ph.D.
Program Director, Blueprint Neurotherapeutics Network
National Institute of Neurological Disorders and Stroke
Telephone: 301-496-1779
Email: charles.cywin@nih.gov

Stephanie Fertig
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone:301-496-1779
Email: fertigs@ninds.nih.gov

Elena Koustova, PhD, MBA
National Institute on Drug Abuse (NIDA)
Telephone: 301-496-8768
Email: koustovae@mail.nih.gov

Michael Oshinsky, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9964
Email: michael.oshinsky@nih.gov

Tanya (Tatiana) Ramey, MD PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-827 5944
Email: tanya.ramey@nih.gov